本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioCryst制药

8.55
0.0000
盘后8.550.0021+0.02%18:41 EDT
成交量:236.41万
成交额:2,024.91万
市值:17.89亿
市盈率:-32.95
高:8.64
开:8.53
低:8.50
收:8.55
数据加载中...

公司资料

公司名字:
BioCryst制药
交易所:
NASDAQ
成立时间:
1986
员工人数:
580
公司地址:
4505 Emperor Boulevard,Suite 200,Durham,North Carolina,United States
邮编:
27703
电话:
传真:
919 859 1314
简介:
BioCryst Pharmaceuticals, Inc.是一家特拉华州公司,最初成立于1986年。该公司是一家全球性生物技术公司,致力于改善遗传性血管性水肿和罕见病患者的生活。该公司利用结构引导药物设计方面的专业知识,目标是开发一流或一流的口服小分子和注射蛋白疗法,以针对难以治疗的罕见疾病。

董事

名称
职位
Jon P. Stonehouse
President, Chief Executive Officer,and Director
Nancy J. Hutson
Chairman of the Board
A. Machelle Sanders
Independent Director
Alan G. Levin
Independent Director
Amy E. McKee
Independent Director
Steven K. Galson
Independent Director
Theresa M. Heggie
Independent Director
Vincent J. Milano
Independent Director
Steven Frank
Director

股东

名称
职位
Jon P. Stonehouse
President, Chief Executive Officer,and Director
Babar Ghias
Chief Financial Officer,Principal Accounting Officer and Head of Corporate Development
Charles K. Gayer
Chief Commercial Officer
Helen M. Thackray
Chief Research and Development Officer